Fuse Vectors ApS
Private limited companyCVR 43610880København NActive
Fuse Vectors ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2022. Equity was negative at the end of 2025 (−DKK 23.7m). The company made a loss in both 2024 and 2025, most recently DKK 16.2m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 9m to DKK 16.2m (2024 → 2025).
- Equity turned negative: −DKK 23.7m (2024 → 2025).
Employees
- 2 fewer employees than a year earlier: 5 (07/2026) against 7 (07/2025).
Management and owners, last 24 months
- New in management: Henrik Stage (chair of the board, 30/12/2024), Jordan Philip Turnbull (board member, 30/12/2024) and Benjamin Andre Frantisek Blaha (board member, 30/12/2024) (+2).
- Stepped down: Henrik Stage (ceo, 01/04/2025) and Jordan Philip Turnbull (director, 31/03/2025).
- New owners registered: HCVC Fund II S.L.P. (30/12/2024).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 30/12/2024: Share capital changed from 42,000 DKK to 48,222 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | −4,390 | −2,545 | −8,944 | −251.5% |
| Operating profit (EBIT) | −6,704 | −9,867 | −14,387 | −45.8% |
| Profit before tax | −7,117 | −10,739 | −18,654 | −73.7% |
| Net profit | −5,759 | −8,987 | −16,200 | −80.3% |
| Total assets | 4,575 | 20,728 | 9,032 | −56.4% |
| Equity | −5,159 | 775 | −23,700 | −3,159.3% |
| Liabilities | 9,734 | 19,954 | 32,732 | +64% |
| Cash and cash equivalents | 2,294 | 2,889 | 3,846 | +33.1% |
| Average number of employees | 5 | 8 | 6 | −25% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 23.7m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 24/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 26/06/2025 | The company | PDFXBRL |
| 2023 | 17/10/2022 – 31/12/2023 | 31/07/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,633of 69,742 Better than 0% | No. 69,810of 69,964 Better than 0% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 305of 323 Better than 6% | No. 323of 329 Better than 2% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,578of 16,614 Better than 0% | No. 16,631of 16,661 Better than 0% |
| All companies of type ApS66,508 companies in the comparison | No. 66,279of 66,379 Better than 0% | No. 66,351of 66,505 Better than 0% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Fuse Vectors ApS−DKK 8.9m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Fuse Vectors ApS−DKK 16.2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Fuse Vectors ApS−DKK 23.7m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Fuse Vectors ApS5
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Next Stage Ventures ApS25%
- Turnbull Biotech ApS25%
- Blaha Bioscience BV25%
- HCVC Fund II S.L.P.10%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Benjamin Andre Frantisek Blaha | Director | 17/10/2022 |
| Jordan Philip Turnbull | CEO | 01/04/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Henrik Stage | Chair of the board | 30/12/2024 |
| Jordan Philip Turnbull | Board member | 30/12/2024 |
| Benjamin Andre Frantisek Blaha | Board member | 30/12/2024 |
| Alexis Alihonou Houssou | Board member | 30/12/2024 |
- Founders
- Next Stage Ventures ApS, Turnbull Biotech ApS, Blaha Bioscience BV
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Henrik Stage | CEO | 17/10/2022 | 01/04/2025 |
| Jordan Philip Turnbull | Director | 17/10/2022 | 31/03/2025 |
Signing rule: Selskabet tegnes af 2 medlemmer af bestyrelsen i forening, af 1 direktør i forening med bestyrelsesformanden, eller af den samlede bestyrelse.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Fuse Vectors ApS | Ole Maaløes Vej 3, 2200 København N | 4 | 1028704654 |
Purpose
Selskabets formål er at udføre forskning og udvikling indenfor bioteknologi.
The purpose is quoted from the register in Danish.
Changes year by year
21 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20255 changesaccounts 1 · management 3 · industry 1
- AccountsAnnual report for 2024 published
- ManagementJordan Philip Turnbull appointed ceo
- ManagementHenrik Stage stepped down as ceo
- ManagementJordan Philip Turnbull stepped down as director
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20247 changescapital 1 · management 4 · ownership 1 · accounts 1
- CapitalShare capital changed from 42,000 DKK to 48,222 DKK
- ManagementJordan Philip Turnbull appointed board member
- ManagementHenrik Stage appointed chair of the board
- ManagementBenjamin Andre Frantisek Blaha appointed board member
- ManagementAlexis Alihonou Houssou appointed board member
- OwnershipHCVC Fund II S.L.P. registered as owner (10%)
- AccountsAnnual report for 2023 published
20231 changeaddress 1
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
20227 changesfounded 1 · management 3 · ownership 3
- FoundedRegistered as Fuse Vectors ApS
- ManagementBenjamin Andre Frantisek Blaha appointed director
- ManagementJordan Philip Turnbull appointed director
- ManagementHenrik Stage appointed ceo
- OwnershipNext Stage Ventures ApS registered as owner (25%)
- OwnershipTurnbull Biotech ApS registered as owner (25%)
- OwnershipBlaha Bioscience BV registered as owner (25%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Adcendo ApSvia Henrik Stage
- Skape Bio ApSvia Henrik Stage
- Synact Pharma ApSvia Henrik Stage
- ResoTher Pharma A/Svia Henrik Stage
- iNotify ApSvia Henrik Stage
- Biomia ApSvia Henrik Stage
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.